Bruker Daltonics, Inc.. (6/3/02). "Press Release: Bruker Daltonics and GeneProt Announce Upgrade of GeneProt’s Mass Spectrometry Capabilities for Its Geneva Proteomics Factory". Billerica, MA.

	Region	United States (USA)
	Organisation	GeneProt Inc.
	Organisation 2	Bruker Daltonics (Group)
	Today	Bruker Corporation (Group)
	Group	Bruker Corporation (Group)
	Product	ultraflex™ MALDI-TOF mass spectrometer
	Product 2	proteomics
	Index term	GeneProt–Bruker Daltonics: mass spectrometer, 200206c supply UltraFlex™ TOF/TOF systems
	Index term 2	GeneProt–Bruker Daltonics: mass spectrometer, 200009– collab MALDI-TOF + ion trap spectrometers for large scale proteomics

Bruker Daltonics Inc. (NASDAQ: BDAL) and GeneProt(TM), Inc. today announced that GeneProt will upgrade its mass spectrometry capabilities at its proteomics factory in Geneva, Switzerland. In December 2001, GeneProt already received a new UltraFlex(TM) TOF/TOF system from Bruker Daltonics for its Geneva proteomics research laboratory. Now, GeneProt has contracted with Bruker Daltonics to upgrade all of its 45 existing ion trap mass spectrometers to the latest esquire3000plus performance level over the next 4-8 months. This is expected to increase the sensitivity and lower the minimum detection levels for low-abundance proteins dramatically, by up to an order of magnitude.

Specifically, GeneProt has converted its November 2001 order for six UltraFlex TOF/TOF systems for its planned North Brunswick, New Jersey facility into an order for upgrading its existing Geneva proteomics facility to state-of-the-art performance. Whilst the new facility in New Jersey, USA remains an option, GeneProt has decided to concentrate its existing resources in Geneva, Switzerland for the remainder of 2002. If GeneProt continues with the expansion of its facilities in the U.S. next year, GeneProt will have the option to acquire UltraFlex TOF/TOF systems for New Jersey at that time.

Frank Laukien, President and CEO of Bruker Daltonics, commented: "We are pleased to continue to work with our partner GeneProt on even further improving their very impressive proteomics capabilities in Geneva. GeneProt has already tested one of our latest-generation esquire3000plus ion trap systems in Geneva, and they have seen a dramatic sensitivity improvement. We are delighted that GeneProt has again chosen cutting-edge ion trap technology for its state-of-the art proteomics facility in Geneva."

ABOUT BRUKER DALTONICS

Bruker Daltonics is a leading developer and provider of innovative life science tools based on mass spectrometry. For more information about Bruker Daltonics, please visit www.bdal.com

CAUTIONARY STATEMENT

Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. Any forward-looking statements contained herein are based on current expectations, but are subject to a number of risks and uncertainties. The factors that could cause actual future results to differ materially from current expectations include, but are not limited to, risks and uncertainties relating to technological approaches, product development, manufacturing, market acceptance, cost and pricing of Bruker Daltonics' products, dependence on collaborative partners, suppliers, FDA and other regulatory approvals to the extent applicable, competition, the intellectual property of others, patent protection and litigation and other risk factors discussed from time to time in Bruker Daltonics' reports or filings with the Securities and Exchange Commission. Bruker Daltonics expressly disclaims any obligation to update the information contained herein.

CONTACT:

Bruker Daltonics Inc.
Michael Willett,
(978) 663-3660, ext. 1411
michael.willett@bdal.com

or

GeneProt Inc.
Bertrand Damour,
(732) 246-8950
Bertrand.damour@geneprot.com

Record changed: 2011-12-21

Follow Us!

Top News

Upcoming Events

Associations

Partners

Bruker Daltonics, Inc.. (6/3/02). "Press Release: Bruker Daltonics and GeneProt Announce Upgrade of GeneProt’s Mass Spectrometry Capabilities for Its Geneva Proteomics Factory". Billerica, MA.

More documents for GeneProt Inc.